Mutations
| Patient No. . | Mutation . | Anti-CD95 MoAb- Induced Apoptosis (%) in Patient* . | Mutation-Positive Relative . | Anti-CD95 MoAb- Induced Apoptosis (%) in Relatives* . | Clinical Manifestations in Relatives . |
|---|---|---|---|---|---|
| 1 | E256K | 6 | De novo | ||
| 2 | Del Exon8(P201fs)† | 6 | De novo | ||
| 3 | G237D | 61 | Father | 30 | 1/1 |
| 4 | I243R | 4 | De novo | ||
| 5 | T254K | 40 | De novo | ||
| 6 | S227fs‡ | 13 | De novo | ||
| 7 | R234P | 12 | Mother | 8 | 1/11-153 |
| Maternal grandfather | 12 | ||||
| 8 | K280fs1-154 | 38 | Father | 49 | 0/1 |
| 9 | V233L | 4 | Mother | 12 | 2/2 |
| 10a | G237S | 23 | Father | 25 | 1/11-153 |
| Brother (10b) | 14 | ||||
| 11 | W265fs1-155 | 19 | Mother | 20 | 0/1 |
| 12a | E63Stop | 23 | Mother | 50 | 3/6 |
| Sister | 53 | ||||
| Cousin (12b) | 40 | ||||
| Cousin (12b’s brother) | 39 | ||||
| Maternal aunt | 35 | ||||
| Maternal grandfather | 45 | ||||
| 13 | S214fs# | 1 | De novo | ||
| 14 | Del Exon8(P201fs)† | 8 | Mother | 7 | 2/2 |
| Patient No. . | Mutation . | Anti-CD95 MoAb- Induced Apoptosis (%) in Patient* . | Mutation-Positive Relative . | Anti-CD95 MoAb- Induced Apoptosis (%) in Relatives* . | Clinical Manifestations in Relatives . |
|---|---|---|---|---|---|
| 1 | E256K | 6 | De novo | ||
| 2 | Del Exon8(P201fs)† | 6 | De novo | ||
| 3 | G237D | 61 | Father | 30 | 1/1 |
| 4 | I243R | 4 | De novo | ||
| 5 | T254K | 40 | De novo | ||
| 6 | S227fs‡ | 13 | De novo | ||
| 7 | R234P | 12 | Mother | 8 | 1/11-153 |
| Maternal grandfather | 12 | ||||
| 8 | K280fs1-154 | 38 | Father | 49 | 0/1 |
| 9 | V233L | 4 | Mother | 12 | 2/2 |
| 10a | G237S | 23 | Father | 25 | 1/11-153 |
| Brother (10b) | 14 | ||||
| 11 | W265fs1-155 | 19 | Mother | 20 | 0/1 |
| 12a | E63Stop | 23 | Mother | 50 | 3/6 |
| Sister | 53 | ||||
| Cousin (12b) | 40 | ||||
| Cousin (12b’s brother) | 39 | ||||
| Maternal aunt | 35 | ||||
| Maternal grandfather | 45 | ||||
| 13 | S214fs# | 1 | De novo | ||
| 14 | Del Exon8(P201fs)† | 8 | Mother | 7 | 2/2 |
The apoptosis observed in the controls are always greater than 80%.
Abbreviation: fs, frameshift.
The data are expressed as the percentage of the apoptosis observed in the control and calculated as follows: (apoptosis observed in the patient)/(apoptosis observed in the control) × 100.
Three missense amino acid codons before stop.
Two missense amino acid codons before stop.
One relative clinically not evaluable.
Forty-one missense amino acid codons before stop.
Ten missense amino acid codons before stop.
#Ten missense amino acid codons before stop.